Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H10N6O |
Molecular Weight | 182.1832 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)\N=N\C1=C(N=CN1)C(N)=O
InChI
InChIKey=FDKXTQMXEQVLRF-ZHACJKMWSA-N
InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9)/b11-10+
Molecular Formula | C6H10N6O |
Molecular Weight | 182.1832 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:09:29 UTC 2023
by
admin
on
Fri Dec 15 16:09:29 UTC 2023
|
Record UNII |
7GR28W0FJI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C902
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
||
|
LIVERTOX |
NBK548913
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
||
|
WHO-ATC |
L01AX04
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
||
|
NDF-RT |
N0000175558
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
||
|
WHO-VATC |
QL01AX04
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.2
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1162308
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
7GR28W0FJI
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
100000088395
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
3232
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
7GR28W0FJI
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
DB00851
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
45388
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
Dacarbazine
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
DACARBAZINE
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
3219
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
4342-03-4
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
C411
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
DTXSID0020369
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
135398738
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
224-396-1
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
CHEMBL476
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
DACARBAZINE
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | Description: A colourless or pale yellow, crystalline powder.Solubility: Slightly soluble in water and ethanol (~750 g/l) TS.Category: Cytotoxic drug.Storage: Dacarbazine should be kept in a tightly closed container, protected from light, and stored at a temperature notexceeding 8 ?C.Additional information: CAUTION: Dacarbazine must be handled with care, avoiding contact with the skin and inhalation ofairborne particles. | ||
|
m4065
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | Merck Index | ||
|
4305
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
SUB06882MIG
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
D003606
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
773
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | |||
|
3098
Created by
admin on Fri Dec 15 16:09:29 UTC 2023 , Edited by admin on Fri Dec 15 16:09:29 UTC 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
Km
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Vmax
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Vmax
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE |
Km
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Km
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
Plasma exposure to AIC was equivalent to that of DTIC, whereas urinary recovery of DTIC and AIC was low and highly variable.
MAJOR
PLASMA
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
PLASMA
|
||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT | |||
|
IMPURITY -> PARENT |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||